APLN and diabetes mellitus: In diabetes or obesity with hyperinsulinemia, increased apelin is a compensatory mechanism in which it not only inhibits pancreatic secretion but also leads to insulin sensitivity and glucose uptake into insulin-independent muscle tissue and then leads to a decrease in apelin levels (31, 88).